Metabolic dysfunction-associated fatty liver disease (MAFLD) is the liver manifestation of a
metabolic syndrome and is highly prevalent in the general population. There has been …

Metabolic dysfunction associated fatty liver disease (MAFLD) is an increasing public health
problem, affecting one third of the global population. Contrary to conventional wisdom …

Importance Dementia and hepatic encephalopathy (HE) are challenging to distinguish
clinically. Undiagnosed cirrhosis in a patient with dementia can lead to missed opportunities …

Background A new fatty liver disease nomenclature, steatotic liver disease (SLD) has been
proposed; however, there are no data on clinical outcomes. We investigated the impact of …

BACKGROUND A new nomenclature consensus has emerged for liver diseases that were
previously known as non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction …

BACKGROUND Metabolic-associated fatty liver disease (MAFLD) is a liver condition marked
by excessive fat buildup in the absence of heavy alcohol use. It is primarily linked with …

Nonalcoholic fatty liver disease (NAFLD) is a pathological syndrome characterized by
excessive fat deposition in hepatocytes. A sedentary lifestyle is a major risk factor for …

Context The presence of metabolic dysfunction–associated steatotic liver disease (MASLD)
in patients with diabetes mellitus (DM) is associated with a high risk of cardiovascular …

The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) is
increasing, affecting over one-third of the global population and contributing to significant …

Background/Objectives: Approximately 25% of the world's population and more than 60% of
patients with type 2 diabetes (T2D) have metabolic-dysfunction-associated steatotic liver …